Zynerba Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$10.8M, a 9.37% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$37.6M, a 0.42% increase year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35M, a 6.09% increase from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$37.3M, a 27.3% increase from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$51.3M, a 55.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$37.6M -$10.8M -$923K -9.37% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$36.7M -$10.1M -$1.62M -19.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-14
Q4 2022 -$35M -$8.02M +$799K +9.06% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$35.8M -$8.68M +$1.91M +18% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$37.7M -$9.85M +$97.1K +0.98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$37.8M -$8.49M -$529K -6.64% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 -$37.3M -$8.82M +$803K +8.35% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$38.1M -$10.6M -$1.53M -17% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$36.6M -$9.95M +$10.4M +51.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$47M -$7.96M +$4.38M +35.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$51.3M -$9.62M +$1.1M +10.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 -$52.4M -$9.05M -$7.1M -365% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$45.3M -$20.3M -$9.2M -82.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$36.1M -$12.3M -$3.19M -34.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$32.9M -$10.7M -$2.92M -37.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$30M -$1.95M +$5.86M +75.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$35.9M -$11.1M +$872K +7.26% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$36.8M -$9.15M +$3.16M +25.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$39.9M -$7.79M +$328K +4.04% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-10
Q3 2018 -$40.2M -$7.81M +$504K +6.06% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$40.7M -$12M -$3.68M -44.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-06
Q1 2018 -$37.1M -$12.3M -$5.05M -69.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-06
Q4 2017 -$32M -$8.12M -$1.22M -17.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-10
Q3 2017 -$30.8M -$8.31M -$2.33M -39% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-14
Q2 2017 -$28.5M -$8.32M -$2.09M -33.6% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-01
Q1 2017 -$26.4M -$7.26M -$2.98M -69.5% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 -$23.4M -$6.9M -$1.46M -26.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-11
Q3 2016 -$21.9M -$5.98M -$1.99M -49.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$19.9M -$6.23M -$4.6M -283% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$15.3M -$4.28M -$2.79M -187% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$12.6M -$5.44M -$4.03M -287% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-14
Q3 2015 -$8.52M -$3.99M -$1.48M -58.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$7.04M -$1.63M -$117K -7.73% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$6.92M -$1.49M -$1.25M -521% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$5.67M -$1.4M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$2.52M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$1.51M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$240K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.